Expert Compares SpaceX and Bezos’ Blue Origin Space Race to the Tortoise and the Hare

Brad Stone, the author of “Amazon Unbound“, compares Elon Musk’s SpaceX to Jeff Bezos’s Blue Origin — referring to them as the tortoise and the hare. But what else separates the two intergalactic competitors? Who will eventually win the space race? Watch below for more.

Host: It’s hard to believe that Blue Origin is actually more than 20 years old and now they’re just getting to their first human launch, but how is Blue Origin different from SpaceX? And how is Elon Musk different from Jeff Bezos?

Stone: It’s incredible. In the empire of accomplishment, Blue Origin for Jeff Bezos is kind of, you know, the tarnished jewel, at least right now.

Host: The ugly stepchild?

Stone: Or let me put it. Let me use the word, the metaphor they use. It’s the tortoise and not the hare. He always wanted to go slow. He wanted to constrain the investment. He wanted to keep the team small, and he wanted to move step by step. And so suborbital or the edge of space and bringing tourists. There was going to be the first step. And then they would get to orbit and then they would go to the moon. And what happened was the hare came along. Elon comes along, finances it with venture capital and then government contracts and gets all the glory. And they do quite well. And I think Bezos has a fair amount of I don’t know if jealousy is the right word, but curiosity that here Elon is getting paid by the government to launch and he is still funding Blue Origin to the tune of a billion in Amazon stock every year. And so we’ve seen Bezos accelerate blue origin’s timetable, its ambitions, its timeline, and see it a little bit of dysfunction over the past few years. And so far, there hasn’t been a lot to show for it.

*Bloomberg contributed to this content

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook –
LinkedIn –

Follow us on social media for the latest updates in B2B!


Revolutionizing the Audit Process: Advancements in Supplier Assessments Within the Pharmaceutical Sector
March 23, 2023

Pharmaceutical companies invest significant resources in research and development to discover new drugs and therapies and improve existing ones. This involves rigorous testing, clinical trials, and obtaining regulatory approval before a drug can be sold. Government agencies, such as the Food and Drug Administration (FDA) in the United States, oversee the approval process and conduct […]

Read More
Disaster Response
Lessons Learned in Disaster Response, Recovery, and Resiliency
March 23, 2023

Natural disasters are one of the most unpredictable, but expected forms of destruction that humanity can expect to happen anywhere and at any time. Unfortunately, many types of disasters result in the loss of life, in addition to wide-scale devastation. When it comes to educational facilities like schools, there’s a certain type of disaster response […]

Read More
How Open-Source IoT Solutions are Redefining the Edge
March 23, 2023

For the tech industry, finding solutions is a daily priority. So, the discovery of new and improved solutions is always a constant goal for the advancement of this. In a new episode of “To the Edge and Beyond,” host Michelle Dawn Mooney interviewed Intel Product Engineer Sean Williams, and IOTech CTO Jim White, to […]

Read More